Abstract:
Nanobody fusion proteins offer a promising platform for developing next-generation biosensors due to their high stability, specificity, and ease of genetic engineering. In this study, a panel of nanobody fusion proteins was designed, produced, and characterized against a set of model and clinically relevant targets, including GFP, GFAP, RSV, IAV, and IBV.

Bio:
A passionate student pursuing a master’s degree in Bioengineering. Throughout the academic career, she has engaged in research projects on designing a home hemodialysis device, developing cutting-edge medical technologies, and optimizing nanobody fusion proteins for electrochemical biosensing. Her academic passion lies in harnessing engineering principles to address complex biology challenges and create innovative solutions to improve the quality of life.